Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
PURE Bioscience (PURE) had Operating Cash Flow per Share of $-0.01 for the most recently reported fiscal quarter, ending 2026-04-30.
| Income Statement Financials | |
$0.51M |
|
$-0.62M |
|
$0.24M |
|
$0.27M |
|
$1.02M |
|
$-0.52M |
|
$-0.11M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.52M |
|
$-0.52M |
|
110.83M |
|
110.83M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$1.55M |
|
$0.01M |
|
$0.01M |
|
$1.56M |
|
$3.65M |
|
$3.74M |
|
$3.74M |
|
$7.40M |
|
$-5.84M |
|
$-5.84M |
|
$-5.84M |
|
130.02M |
|
| Cash Flow Statement Financials | |
$-1.32M |
|
-- |
|
$1.97M |
|
$0.41M |
|
$1.06M |
|
$0.65M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.42 |
|
-- |
|
-- |
|
-1.79 |
|
-1.11 |
|
53.16% |
|
-102.37% |
|
-102.37% |
|
-- |
|
-123.32% |
|
-123.32% |
|
$-1.32M |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
1.02 |
|
2.09 |
|
43.04 |
|
10.69% |
|
10.69% |
|
-40.05% |
|
29.77% |
|
$-0.04 |
|
$-0.01 |
|
|
Operating Cash Flow per Share |
$-0.01 |